Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance1 1The Bundesministerium für Bildung und Forschung and the European Union, as sponsors of the study, had no role in study design, data collection, analysis, or interpretation or in the writing and the decision to submit the report for publication.

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

2001 • 6,133 citations

The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994

1999 • 3,083 citations

Peginterferon Alfa-2a in Patients with Chronic Hepatitis C

2000 • 1,246 citations

Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection

2001 • 1,183 citations

Clinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune Globulin

1999 • 913 citations

Peginterferon Alfa-2a in Patients with Chronic Hepatitis C and Cirrhosis

2000 • 893 citations

The Outcome of Acute Hepatitis C Predicted by the Evolution of the Viral Quasispecies

2000 • 892 citations

Treatment of Acute Hepatitis C with Interferon Alfa-2b

2001 • 818 citations

Recovery, Persistence, and Sequelae in Hepatitis C Virus Infection: A Perspective on Long-Term Outcome

2000 • 751 citations

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

2000 • 747 citations

The Declining Risk of Post-Transfusion Hepatitis C Virus Infection

1992 • 727 citations

Recurrence of hepatitis C virus after loss of virus-specific CD4+ T-cell response in acute hepatitis C

1999 • 716 citations

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

1995 • 702 citations

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.

1996 • 669 citations

Prevalence and Clinical Outcome of Hepatitis C Infection in Children Who Underwent Cardiac Surgery before the Implementation of Blood-Donor Screening

1999 • 482 citations

Association of Hepatitis C Virus–Specific CD8⁺T Cells with Viral Clearance in Acute Hepatitis C

2000 • 362 citations

Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus.

1997 • 333 citations

Epidemiology of hepatitis C in the United States

1999 • 233 citations

Resolution of acute hepatitis C after therapy with natural beta interferon

1991 • 190 citations

Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity

1998 • 141 citations

A multicenter randomized controlled trial of recombinant interferon-α2b in patients with acute transfusion-associated hepatitis C

1994 • 105 citations

Interferon-α in acute posttransfusion hepatitis C:. A randomized, controlled trial

1992 • 94 citations

High-dose interferon-α2b treatment prevents chronicity in acute hepatitis C

1996 • 91 citations

Interferon as treatment for acute hepatitis C

1996 • 85 citations

Effects of interferon beta on non-A, non-B acute hepatitis: A prospective, randomized, controlled-dose study

1994 • 83 citations

A randomized controlled trial of recombinant interferon α-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C

1994 • 74 citations

Methods for the differentiation of microorganisms

1999 • 65 citations

Interferon therapy for acute posttransfusion non-A, non-B hepatitis: response with respect to anti-hepatitis C virus antibody status.

1991 • 35 citations

Prevalence and Clinical Outcome of Hepatitis C Infection in Children Who Underwent Cardiac Surgery Before the Implementation of Blood-Donor Screening

2000 • 34 citations

Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis.

1993 • 31 citations

HCV RNA in blood donors with isolated reactivities by third‐generation RIBA

2000 • 19 citations

INTERFERON THERAPY FOR ACUTE POSTTRANSFU-SION NON-A, NON-B HEPATITIS

1992 • 3 citations